Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,098Revenue $M45.6Net Margin (%)-601.7Z-Score-3.5
Enterprise Value $M1,044EPS $-1.5Operating Margin %-600.4F-Score3
P/E(ttm))0Cash Flow Per Share $-0.8Pre-tax Margin (%)-600.8Higher ROA y-yY
Price/Book7.410-y EBITDA Growth Rate %0Quick Ratio3.0Cash flow > EarningsY
Price/Sales21.75-y EBITDA Growth Rate %0Current Ratio3.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-73.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-147.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M187ROI % (ttm)-83.9Gross Margin Increase y-yN

Gurus Latest Trades with ARIA

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARIAGeorge Soros 2014-03-31 Reduce-0.08%$6.46 - $8.99
($7.75)
$ 5.88-24%Reduce -74.36%500,000
ARIAGeorge Soros 2013-12-31 Buy 0.11%$2.2 - $18.8
($5.16)
$ 5.8814%New holding, 1950000 sh.1,950,000
ARIADaniel Loeb 2013-06-30 Sold Out -0.94%$16.32 - $19.77
($17.73)
$ 5.88-67%Sold Out0
ARIADaniel Loeb 2012-12-31 Add0.4%$18.93 - $25.16
($22.12)
$ 5.88-73%Add 85.19%2,500,000
ARIADaniel Loeb 2012-09-30 Reduce-0.39%$17.11 - $24.21
($19.85)
$ 5.88-70%Reduce -35.71%1,350,000
ARIADaniel Loeb 2012-06-30 Buy 1.1%$14.6 - $17.82
($16.35)
$ 5.88-64%New holding, 2100000 sh.2,100,000
ARIAGeorge Soros 2012-06-30 Sold Out -0.15%$14.6 - $17.82
($16.35)
$ 5.88-64%Sold Out0
ARIAGeorge Soros 2012-03-31 Buy 0.15%$12.73 - $16.32
($13.74)
$ 5.88-57%New holding, 635000 sh.635,000
ARIAGeorge Soros 2011-12-31 Sold Out -0.07%$8.03 - $12.5
($10.96)
$ 5.88-46%Sold Out0
ARIAGeorge Soros 2011-09-30 Buy 0.07%$7.63 - $13.34
($10.54)
$ 5.88-44%New holding, 496847 sh.496,847
ARIAJean-Marie Eveillard 2008-06-30 Buy $2.39 - $3.57
($2.8)
$ 5.88110%New holding, 50000 sh.50,000
ARIAGeorge Soros 2008-06-30 Sold Out -0.01%$2.39 - $3.57
($2.8)
$ 5.88110%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARIA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ARIA George Soros 2014-03-31500,0000.270.04-74.36%
Premium Most recent portfolio changes are included for Premium Members only!


ARIA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cantor Maria ESVP, Corporate Affairs and HR 2014-06-02Sell3,713$6.9-26.09view
CLACKSON TIMOTHY PPresident, R&D, CSO 2014-04-02Sell6,500$8.21-37.88view
Cantor Maria ESVP, Corporate Affairs and HR 2014-04-02Sell4,250$8.21-37.88view
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2014-04-02Sell2,400$8.22-37.96view
BERSTEIN DAVID LSVP, GC and Chief IP Officer 2014-04-02Sell2,400$8.22-37.96view
Haluska FrankSVP, Clinical R&D, CMO 2014-04-02Sell3,400$8.21-37.88view
BERSTEIN DAVID LSVP, GC and Chief IP Officer 2014-03-21Sell1,600$7.89-35.36view
Cantor Maria ESVP, Corporate Affairs and HR 2014-03-21Sell3,667$7.89-35.36view
Haluska FrankSVP, Clinical R&D, CMO 2014-03-21Sell2,400$7.89-35.36view
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2014-03-21Sell2,400$7.89-35.36view

Press Releases about ARIA :

Quarterly/Annual Reports about ARIA:

News about ARIA:

Articles On GuruFocus.com
Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A Apr 07 2014 
Weekly CEO Sells Highlight: U.S. Bancorp, Restoration Hardware Holdings Inc, Ariad Pharmaceuticals, Jul 20 2013 
Daniel Loeb's Top Three Increases of the First Quarter May 24 2013 
comment on ARIA Mar 15 2013 
comment on ARIA Mar 15 2013 
comment on ARIA May 16 2012 
Weekly CFO Sales Highlight: WWWW, FIO, CRIS, ARIA, VOG, APKT Apr 22 2012 
3 Biotech Stocks To Consider Buying Right Now Jan 10 2012 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
creiter note on ARIA Jan 03 2010 

More From Other Websites
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results Jul 16 2014
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results Jul 16 2014
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe Jul 14 2014
ARIAD Pharmaceuticals (ARIA) Is Water-Logged And Getting Wetter Today Jul 08 2014
UCB, Dermira Sign Cimzia Dermatology Deal Jul 07 2014
Why A Short Covering Rally Might Come for Ariad Pharmaceuticals (ARIA) Stock Jul 07 2014
Zogenix, Inc. (ZGNX) Soars: Stock Adds 18.6% in Session Jul 03 2014
Amgen Gets Breakthrough Therapy Status for Leukemia Drug Jul 02 2014
Karyopharm Therapeutics (KPTI) in Focus: Stock Goes Down 5.2% Jul 02 2014
Salix Pharmaceuticals (SLXP) Soars: Stock Adds 11.4% in Session Jul 02 2014
Auxilium Pharmaceuticals (AUXL) Crumbles: Stock Falls by 5.6% Jul 01 2014
UCB's Vimpat Positive for Partial-Onset Seizures Jun 30 2014
QLT Inc. (QLTI) in Focus: Stock Surges 14.63% Jun 27 2014
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Jun 26 2014
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jun 24 2014
Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% Jun 24 2014
Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher Jun 20 2014
BioLineRx to Commence BL-8040 Study Jun 19 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide